Homology Medicines Overview

  • Founded
  • 2015
Founded
  • Status
  • Public
  • Employees
  • 206
Employees
  • Stock Symbol
  • FIXX
Stock Symbol
  • Share Price
  • $12.94
  • (As of Friday Closing)

Homology Medicines General Information

Description

Homology Medicines Inc is an US based is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 45 Wiggins Avenue
  • Bedford, MA 01730
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Homology Medicines Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$12.94 $13.17 $8.70 - $22.38 $586M 45.3M 626K -$2.74

Homology Medicines Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 293,794 641,845 600,861
Revenue 2,285 1,666 5,322 0
EBITDA (118,392) (103,625) (58,637) (29,849)
Net Income (123,070) (103,916) (55,577) (29,991)
Total Assets 228,362 310,567 259,094 137,530
Total Debt 16,037 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Homology Medicines Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Homology Medicines‘s full profile, request access.

Request a free trial

Homology Medicines Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Homology Medicines‘s full profile, request access.

Request a free trial

Homology Medicines Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Homology Medicines Inc is an US based is a genetic medicines company dedicated to transforming the lives of patients suf
Biotechnology
Bedford, MA
206 As of 2020
00000
0000 0000-00-00
00000000 00000

00000000

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
00000 0000000000 00000000
Rockville, MD
000 As of 0000
00000
000000000 00000

000 0000

cididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamc
0000 000000000
South San Francisco, CA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Homology Medicines Competitors (68)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regenxbio Formerly VC-backed Rockville, MD 000 00000 000000000 00000
000 00000000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000000 00000
0000 000000 Formerly VC-backed San Diego, CA 00 00000 00000000 00000
00000000 000000000 Private Equity-Backed San Francisco, CA 000 00000 000000&0 00000
0000 Formerly VC-backed Emeryville, CA 00 00000 00000000 00000
You’re viewing 5 of 68 competitors. Get the full list »

Homology Medicines Executive Team (11)

Name Title Board Seat Contact Info
Arthur Tzianabos Ph.D President, Board Member & Chief Executive Officer
Bradford Smith Chief Financial Officer
Albert Seymour Ph.D Chief Scientific Officer
CJ Witalisz Executive
Saswati Chatterjee Ph.D Co-Founder and Chair of the Scientific Advisory Board
You’re viewing 5 of 11 executive team members. Get the full list »

Homology Medicines Board Members (14)

Name Representing Role Since
Alise Reicin MD Self Board Member 000 0000
Arthur Tzianabos Ph.D Homology Medicines President, Board Member & Chief Executive Officer 000 0000
Cameron Wheeler Ph.D Self Board Member 000 0000
Jason Ruth Ph.D 5AM Ventures Board Observer 000 0000
Jeffrey Poulton Self Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Homology Medicines Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Homology Medicines Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Homology Medicines‘s full profile, request access.

Request a free trial